@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix biolink: . @prefix ns1: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { a biolink:Disease . sub:association rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a rdf:Statement; rdfs:label "TCAs can serve as first-line or augmenting drugs for neuropathic pain, headache, migraine, gastrointestinal syndromes, fibromyalgia, pelvic pain, insomnia, and psychiatric conditions other than depression."; biolink:has_population_context sub:context; biolink:provided_by ; biolink:publications ; biolink:relation . sub:context a biolink:Cohort; rdfs:label "adults" . a biolink:Drug . } sub:provenance { sub:assertion prov:generatedAtTime "2021-08-16T20:37:20.925746"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"; npx:hasSignature "F8PBztFdWUPvi+/B8qbqBEpzgLlsrgjiD6QsuGC5EVP6l0htjKB0fMSRSrdxUpnBhFXM4VNCoOrXKmpUAE5s0dO0CBI6bJX+NOonK54xBZeVI5d8zPnGxkPg25+Ta1l+IxZMvC3JaVLNhU1sDNoFhKbccpGvLQC8s7p3slStatA="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-08-16T20:37:20.925746"^^xsd:dateTime; prov:wasAttributedTo ; ns1:wasCreatedFromTemplate . }